Clinical Trials Browser

Phase 1/2 × Trabedersen × Clear all

NCT06579196 2025-07-24

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung